The Natural History of Acanthamoeba Keratitis: A Systematic Literature Review

Vincenzo Papa1, Danielle H Bodicoat2, Angela Arteaga Duarte2

  • 1SIFI S.P.A., 36, Via Ercole Patti, 95025, Aci S. Antonio, Catania, Italy. Vincenzo.Papa@sifigroup.com.

PubMed
Abstract

Insights

Before effective anti-amoebic treatments, Acanthamoeba keratitis (AK) outcomes were poor. Most patients required therapeutic keratoplasty (TK) or enucleation, with few achieving medical cure without surgery.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Microbiology

Background:

  • Acanthamoeba keratitis (AK) is a severe eye infection.
  • Early AK treatments were ineffective, leading to poor outcomes and frequent surgical interventions.
  • Understanding historical treatment outcomes provides a benchmark for current therapies.

Purpose of the Study:

  • To evaluate the treatment outcomes of Acanthamoeba keratitis before the availability of effective anti-amoebic agents.
  • To describe the natural history of AK during a period of limited therapeutic options.
  • To establish a historical benchmark for comparing current AK treatment efficacy.

Main Methods:

  • Systematic literature review adhering to PRISMA guidelines for studies published between 1970 and 1995.
  • Inclusion criteria: AK patients treated without established anti-amoebic agents (biguanides or diamidines).
  • Outcomes assessed: medical cure, therapeutic keratoplasty (TK), and enucleation, with proportion and confidence interval estimation.

Main Results:

  • Fifty-six case reports were analyzed, with contact lens wear (68.2%) and trauma (31.8%) as primary risk factors.
  • Average diagnosis delay was 7.3 weeks; only 23.2% were diagnosed within 4 weeks.
  • Medical cure rate was 19.6%, while 67.9% required TK and 5.4% underwent enucleation.

Conclusions:

  • Prior to effective treatments like propamidine, Acanthamoeba keratitis had a poor prognosis.
  • Surgical intervention, particularly therapeutic keratoplasty, was the predominant outcome.
  • Findings highlight the significant impact of early anti-amoebic therapies on AK patient outcomes.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
75